NATCO invests US$ 2 million in Cellogen Therapeutics
Both these innovations are aimed at reducing the risk of relapse post CAR T cell therapy
Both these innovations are aimed at reducing the risk of relapse post CAR T cell therapy
Agreed Price of US$43 per share to deliver 48% premium to unaffected price on May 25, 2023
The bold, dynamic, and new logo unveiled in this process captures the essence of the 'Better Together' theme
The certification underscores Venus Remedies Limited's adherence to stringent quality control measures
The company disclosed that several employees of a subsidiary had their business email addresses stolen
Automated parallel capillary electrophoresis system simplifies protein analysis
Microdosing has emerged as a key trend in the pharmaceutical and nutritional markets
The Aptivate Champion Run witnessed an enthusiastic participation of over 4,000 Mumbaikars
PharmaLogic will assist ARTBIO with radiochemistry and supply of the finished radiopharmaceutical product for future Phase I and II clinical trials of AB001 from their facility in New York
Subscribe To Our Newsletter & Stay Updated